ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
August 15, 2019Implied total company value of up to $1 billion, inclusive of 40.8 percent stake currently held by Bayer / Initial focus in neurology, cardiology, and immunology with start of first clinical program in Parkinson’s disease expected later this year / BlueRo
Pharma Sources Insight January 2025
